DNA sequence repeats identify numerous Type I restriction‐modification systems that are potential epigenetic regulators controlling phase‐variable regulons; phasevarions
Abstract:Over recent years several examples of randomly switching methyltransferases, associated with Type III restriction-modification (R-M) systems, have been described in pathogenic bacteria. In every case examined, changes in simple DNA sequence repeats result in variable methyltransferase expression and result in global changes in gene expression, and differentiation of the bacterial cell into distinct phenotypes.These epigenetic regulatory systems are called phasevarions, phase-variable regulons, and are widespre… Show more
“…Our systematic analysis of REBASE identified Type I loci containing multiple hsdS genes where we detect IRs in a range of commensal organisms, such as Bacteroides fragilis and multiple Ruminococcus species, in environmental bacterial species such as Leuconostoc mesenteroides and in a number of Lactobacillus species that are important to the biotechnology and food production industries (Data Set S3). This reflects our previous studies where we observed simple sequence repeats that mediate phase variation in multiple Type I (14) and Type III methyltransferase genes (13) present in a variety of commensal and environmental organisms.…”
Section: Discussionsupporting
confidence: 89%
“…A broad range of bacterial species encode these systems. Our previous work showed that 2% of Type I hsdM and 7.9% of Type I hsdS genes contain SSRs (14). Together with our findings in this study, this means that 13.8% of all Type I systems are capable of phase-variable expression.…”
Section: Discussionsupporting
confidence: 85%
“…Many of the veterinary pathogens that we show contain inverting Type I loci also contain separate, distinct Type III or Type I R-M systems that are capable of phase varying via changes in locus located simple sequence repeats. These species include Actinobacillus pleuropneumoniae , Mannheimia haemolytica , Streptococcus suis , Glaesserella ( Haemophilus ) parasuis , and multiple Mycoplasma species ( 13 , 14 ). This means that all of these veterinary pathogens have evolved phase variation of both Type I and Type III methyltransferases, and in the case of Type I systems, by both SSR tract length changes ( 14 ) and by recombination between variable hsdS genes containing IRs (this study).…”
Section: Discussionmentioning
confidence: 99%
“…These species include Actinobacillus pleuropneumoniae , Mannheimia haemolytica , Streptococcus suis , Glaesserella ( Haemophilus ) parasuis , and multiple Mycoplasma species ( 13 , 14 ). This means that all of these veterinary pathogens have evolved phase variation of both Type I and Type III methyltransferases, and in the case of Type I systems, by both SSR tract length changes ( 14 ) and by recombination between variable hsdS genes containing IRs (this study). For example, A. pleuropneumoniae encodes two distinct Type III methyltransferase ( mod ) genes containing simple sequence repeats ( 13 ), and a Type I system containing variable hsdS loci where IRs are present (this study; Fig.…”
Section: Discussionmentioning
confidence: 99%
“…Several bacterial pathogens also contain well-characterized cytoplasmic N 6 -adenine DNA methyltransferases, which are part of restriction-modification (R-M) systems, that exhibit phase-variable expression. We recently characterized the distribution of SSR tracts in Type III mod genes and Type I hsdS , hsdM , and hsdR genes in the REBASE database of R-M systems, and we demonstrated that 17.4% of all Type III mod genes ( 13 ) and 10% of all Type I R-M systems contain SSRs that are capable of undergoing phase-variable expression ( 14 ). Phase variation of methyltransferase expression leads to genome-wide methylation differences, which can result in differential regulation of multiple genes in systems known as phasevarions ( phase-vari able regul on ).…”
N6-Adenine DNA methyltransferases associated with some Type I and Type III restriction-modification (R-M) systems are able to undergo phase variation, randomly switching expression ON or OFF by varying the length of locus-encoded simple sequence repeats (SSRs). This variation of methyltransferase expression results in genome-wide methylation differences and global changes in gene expression. These epigenetic regulatory systems are called phasevarions, phase-variable regulons, and are widespread in bacteria. A distinct switching system has also been described in Type I R-M systems, based on recombination-driven changes in hsdS genes, which dictate the DNA target site. In order to determine the prevalence of recombination-driven phasevarions, we generated a program called RecombinationRepeatSearch to interrogate REBASE and identify the presence and number of inverted repeats of hsdS downstream of Type I R-M loci. We report that 3.9% of Type I R-M systems have duplicated variable hsdS genes containing inverted repeats capable of phase variation. We report the presence of these systems in the major pathogens Enterococcus faecalis and Listeria monocytogenes, which could have important implications for pathogenesis and vaccine development. These data suggest that in addition to SSR-driven phasevarions, many bacteria have independently evolved phase-variable Type I R-M systems via recombination between multiple, variable hsdS genes.
IMPORTANCE Many bacterial species contain DNA methyltransferases that have random on/off switching of expression. These systems, called phasevarions (phase-variable regulons), control the expression of multiple genes by global methylation changes. In every previously characterized phasevarion, genes involved in pathobiology, antibiotic resistance, and potential vaccine candidates are randomly varied in their expression, commensurate with methyltransferase switching. Our systematic study to determine the extent of phasevarions controlled by invertible Type I R-M systems will provide valuable information for understanding how bacteria regulate genes and is key to the study of physiology, virulence, and vaccine development; therefore, it is critical to identify and characterize phase-variable methyltransferases controlling phasevarions.
“…Our systematic analysis of REBASE identified Type I loci containing multiple hsdS genes where we detect IRs in a range of commensal organisms, such as Bacteroides fragilis and multiple Ruminococcus species, in environmental bacterial species such as Leuconostoc mesenteroides and in a number of Lactobacillus species that are important to the biotechnology and food production industries (Data Set S3). This reflects our previous studies where we observed simple sequence repeats that mediate phase variation in multiple Type I (14) and Type III methyltransferase genes (13) present in a variety of commensal and environmental organisms.…”
Section: Discussionsupporting
confidence: 89%
“…A broad range of bacterial species encode these systems. Our previous work showed that 2% of Type I hsdM and 7.9% of Type I hsdS genes contain SSRs (14). Together with our findings in this study, this means that 13.8% of all Type I systems are capable of phase-variable expression.…”
Section: Discussionsupporting
confidence: 85%
“…Many of the veterinary pathogens that we show contain inverting Type I loci also contain separate, distinct Type III or Type I R-M systems that are capable of phase varying via changes in locus located simple sequence repeats. These species include Actinobacillus pleuropneumoniae , Mannheimia haemolytica , Streptococcus suis , Glaesserella ( Haemophilus ) parasuis , and multiple Mycoplasma species ( 13 , 14 ). This means that all of these veterinary pathogens have evolved phase variation of both Type I and Type III methyltransferases, and in the case of Type I systems, by both SSR tract length changes ( 14 ) and by recombination between variable hsdS genes containing IRs (this study).…”
Section: Discussionmentioning
confidence: 99%
“…These species include Actinobacillus pleuropneumoniae , Mannheimia haemolytica , Streptococcus suis , Glaesserella ( Haemophilus ) parasuis , and multiple Mycoplasma species ( 13 , 14 ). This means that all of these veterinary pathogens have evolved phase variation of both Type I and Type III methyltransferases, and in the case of Type I systems, by both SSR tract length changes ( 14 ) and by recombination between variable hsdS genes containing IRs (this study). For example, A. pleuropneumoniae encodes two distinct Type III methyltransferase ( mod ) genes containing simple sequence repeats ( 13 ), and a Type I system containing variable hsdS loci where IRs are present (this study; Fig.…”
Section: Discussionmentioning
confidence: 99%
“…Several bacterial pathogens also contain well-characterized cytoplasmic N 6 -adenine DNA methyltransferases, which are part of restriction-modification (R-M) systems, that exhibit phase-variable expression. We recently characterized the distribution of SSR tracts in Type III mod genes and Type I hsdS , hsdM , and hsdR genes in the REBASE database of R-M systems, and we demonstrated that 17.4% of all Type III mod genes ( 13 ) and 10% of all Type I R-M systems contain SSRs that are capable of undergoing phase-variable expression ( 14 ). Phase variation of methyltransferase expression leads to genome-wide methylation differences, which can result in differential regulation of multiple genes in systems known as phasevarions ( phase-vari able regul on ).…”
N6-Adenine DNA methyltransferases associated with some Type I and Type III restriction-modification (R-M) systems are able to undergo phase variation, randomly switching expression ON or OFF by varying the length of locus-encoded simple sequence repeats (SSRs). This variation of methyltransferase expression results in genome-wide methylation differences and global changes in gene expression. These epigenetic regulatory systems are called phasevarions, phase-variable regulons, and are widespread in bacteria. A distinct switching system has also been described in Type I R-M systems, based on recombination-driven changes in hsdS genes, which dictate the DNA target site. In order to determine the prevalence of recombination-driven phasevarions, we generated a program called RecombinationRepeatSearch to interrogate REBASE and identify the presence and number of inverted repeats of hsdS downstream of Type I R-M loci. We report that 3.9% of Type I R-M systems have duplicated variable hsdS genes containing inverted repeats capable of phase variation. We report the presence of these systems in the major pathogens Enterococcus faecalis and Listeria monocytogenes, which could have important implications for pathogenesis and vaccine development. These data suggest that in addition to SSR-driven phasevarions, many bacteria have independently evolved phase-variable Type I R-M systems via recombination between multiple, variable hsdS genes.
IMPORTANCE Many bacterial species contain DNA methyltransferases that have random on/off switching of expression. These systems, called phasevarions (phase-variable regulons), control the expression of multiple genes by global methylation changes. In every previously characterized phasevarion, genes involved in pathobiology, antibiotic resistance, and potential vaccine candidates are randomly varied in their expression, commensurate with methyltransferase switching. Our systematic study to determine the extent of phasevarions controlled by invertible Type I R-M systems will provide valuable information for understanding how bacteria regulate genes and is key to the study of physiology, virulence, and vaccine development; therefore, it is critical to identify and characterize phase-variable methyltransferases controlling phasevarions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.